义眼
Search documents
济南爱尔眼科携手美目医疗开启义眼定制临床应用新篇章
Qi Lu Wan Bao· 2026-02-26 09:25
Core Viewpoint - The collaboration between Jinan Aier Eye Hospital and Meimu Medical aims to enhance the quality of customized prosthetic eye services, addressing the needs of patients with eye defects and improving their confidence and quality of life [1][3][5]. Group 1: Collaboration Significance - The partnership is a crucial step in expanding the service boundaries of Jinan Aier Eye Hospital, aligning with the "whole lifecycle eye health" concept [3][5]. - The introduction of customized prosthetic eye services will fill the gap in high-quality services in the region, allowing patients to access professional care without traveling to major cities [3][11]. Group 2: Clinical Value - The collaboration will leverage the hospital's clinical strengths to provide precise pre-operative assessments, intra-operative adaptations, and post-operative follow-up support for prosthetic eye customization [5][9]. - A customized prosthetic eye is essential for patients to regain social confidence and return to normal life, addressing both aesthetic and psychological needs [5][7]. Group 3: Patient-Centric Approach - The partnership emphasizes a patient-centered service philosophy, optimizing service processes and providing personalized care, including green channels for appointments and post-operative guidance [7][11]. - The initiative aims to enhance patient dignity and confidence through high-quality prosthetic eye services, incorporating psychological support and educational outreach [7][11]. Group 4: Technological Advancements - Meimu Medical has developed advanced polymer prosthetic eye technology, achieving realistic effects that set industry standards [9][11]. - The collaboration will focus on continuously upgrading the customization technology to meet patient needs more effectively [9][11]. Group 5: Future Outlook - The partnership is expected to promote the standardization and personalization of prosthetic eye services in Jinan and surrounding areas, contributing to the "Healthy China 2030" strategy in the field of ophthalmology [11].